March 14, 2018 - By Ellis Scott

The stock of CANOPY GROWTH CORPORATION ORDINARY SHARE (OTCMKTS:TWMJF) registered an increase of 5.44% in short interest. TWMJF’s total short interest was 6.95 million shares in March as published by FINRA. Its up 5.44% from 6.59M shares, reported previously. With 2.86 million shares average volume, it will take short sellers 2 days to cover their TWMJF’s short positions. The short interest to CANOPY GROWTH CORPORATION ORDINARY SHARE’s float is 4.18%.

The stock decreased 1.07% or $0.26 during the last trading session, reaching $24.28. About 174,235 shares traded. Canopy Growth Corporation (OTCMKTS:TWMJF) has 0.00% since March 14, 2017 and is . It has underperformed by 16.70% the S&P500.

Canopy Growth Corporation, through its subsidiaries, produces and sells medical marijuana in Canada. The company has market cap of $4.85 billion. The firm offers dried, oil, and softgel cannabis products. It currently has negative earnings. Canopy Growth Corporation also sells its products through online.

More notable recent Canopy Growth Corporation (OTCMKTS:TWMJF) news were published by: which released: “Canopy Growth, Aurora Cannabis, Cronos Group: Investors on Hold Awaiting Catalysts” on March 13, 2018, also with their article: “S&P/TSX Composite Index Today: Aurora Cannabis Inc, Canopy Growth and Aphria …” published on March 12, 2018, published: “Canopy Growth Corp and Cronos Group Inc Helped Propel Cannabis Stocks 28% In …” on March 07, 2018. More interesting news about Canopy Growth Corporation (OTCMKTS:TWMJF) were released by: and their article: “Canopy’s latest acquisition target is a bit peculiar” published on March 14, 2018 as well as‘s news article titled: “Canopy Growth Partner Valens Groworks Corp Cranks Up Extraction Operations” with publication date: March 12, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: